Keyphrases
Maternal Health
100%
Randomized Clinical Trial
100%
Antiretroviral Therapy
100%
Antiretroviral Therapy Interruption
100%
HIV+
50%
CD4 Count
25%
Progression to AIDS
25%
Zidovudine
12%
Africa
12%
Follow-up Time
12%
Disease Progression
12%
During Pregnancy
12%
Adverse Events
12%
India
12%
HIV-related
12%
Combined Antiretroviral Therapy (cART)
12%
WHO Grade
12%
Treatment Interruption
12%
Cell Count
12%
Second Analysis
12%
Progression Rate
12%
Clinical Stage I
12%
Antepartum
12%
Reassurance
12%
Black African
12%
Formula Feeding
12%
Maternal Health Outcomes
12%
Pregnant Women Living with HIV
12%
WHO Clinical Stage
12%
Grade 23
12%
Medicine and Dentistry
Maternal Welfare
100%
Randomized Clinical Trial
100%
Antiretroviral Therapy
100%
Treatment Interruption
100%
Human Immunodeficiency Virus
54%
Exposure Therapy
27%
Arm
18%
Disease Exacerbation
9%
Lifespan
9%
Adverse Event
9%
Clinical Stage
9%
Cell Count
9%
Health Outcomes
9%
Zidovudine
9%
Reassurance
9%
Biochemistry, Genetics and Molecular Biology
Human Immunodeficiency Virus
100%
Randomized Clinical Trial
100%
Treatment Interruption
100%
CD4 Lymphocyte Count
33%
Lifespan
16%
Cell Count
16%
Zidovudine
16%
Reassurance
16%
Pharmacology, Toxicology and Pharmaceutical Science
HIV
100%
Randomized Clinical Trial
100%
Adverse Event
16%
Disease Exacerbation
16%
Zidovudine
16%
Immunology and Microbiology
Human Immunodeficiency Virus
100%
CD4 Lymphocyte Count
33%
Arm
33%
Lifespan
16%
Cell Count
16%